rethinkPeptides Search
Menu
Study breakdown

Goat Spine Model Shows Disc Degeneration Triggers Nerve and Immune Inflammation

evidence
The takeaway

Chemically induced disc degeneration in goats triggered neuroimmune activation with upregulation of inflammatory neuropeptides including CGRP and substance P.

CGRP and substance P upregulated

Neuroimmune activation in degenerated goat cervical discs

What the researchers found

Disc degeneration in a goat model triggered neuroimmune activation with increased CGRP and substance P expression in degenerated discs and adjacent tissues.

Why it matters

Understanding the neuroimmune response to disc degeneration is essential for developing targeted therapies for discogenic back pain, which affects millions.

How the study worked

Large animal model using intradiscal chondroitinase ABC injection in goat cervical spine, with immunohistochemical assessment of disc pathology and neuroinflammatory markers.

What this study cannot tell us

Chemical induction may not perfectly mimic natural age-related degeneration; goat cervical spine differs from human lumbar spine; relatively short follow-up.

How to read the evidence

Large animal model study — more translationally relevant than small animal studies but still preclinical.

When this study was published

Published 2026 in Cells.

The bigger picture

Neuropeptide-mediated inflammation in disc degeneration suggests anti-CGRP or anti-substance P therapies (already used for migraine) could potentially treat discogenic pain.

Questions still open

  • Could anti-CGRP migraine therapies be repurposed for discogenic back pain?
  • Does the neuroimmune response differ between cervical and lumbar disc degeneration?

Common questions

How does disc degeneration cause pain?
This study shows that damaged discs produce inflammatory peptides (CGRP, substance P) that activate nearby nerves, creating a neuroinflammatory cycle that generates pain signals.
Could migraine drugs help back pain?
Potentially — CGRP-blocking drugs used for migraine might target the same pain peptide found in degenerated discs, though this needs specific clinical testing.

Read the original research

Neuroimmune Activation in a Goat Model of Intervertebral Disc Degeneration.

Cells, 15(3)

Citation

Augustin, Janai A; Burt, Kevin G; Barrett, Caitlin; Fainor, Matthew; Orozco, Brianna S; Schaer, Thomas P; Smith, Harvey E; Mauck, Robert L; Gullbrand, Sarah E. (2026). Neuroimmune Activation in a Goat Model of Intervertebral Disc Degeneration.. Cells, 15(3). https://doi.org/10.3390/cells15030286